OR WAIT null SECS
© 2023 MJH Life Sciences and BioPharm International. All rights reserved.
© 2023 MJH Life Sciences™ and BioPharm International. All rights reserved.
November 15, 2023
Demand for efficient tech transfer, as well as compliant on-time delivery, is rising.
November 01, 2023
A look at using best practice tech transfer methods for CGTs to increase process and analytics robustness while being scalable.
October 13, 2023
Under an expanded agreement, Cellares will provide proof-of-concept manufacturing for a second CAR-T cell therapy from Bristol Myers Squibb.
October 11, 2023
Under this agreement, Acuitas Therapeutics’ LNP technology platform will be transferred to BIOVECTRA for use in manufacturing mRNA-based therapies.
May 15, 2023
The complexity of the pharmaceutical product brings challenges to the transfer of information and technology between sponsors and contractors.
November 01, 2022
In this article, the potential pitfalls of technology transfers are discussed as well as ways to ensure a smooth transition.
October 25, 2022
Under two new agreements, Societal CDMO will offer analytical, technical transfer, formulation, manufacturing, and packaging services for novel therapeutics.
December 01, 2021
Partnerships formed during the COVID-19 pandemic have provided a platform for change in assay development and transfers that should continue in the future.
December 03, 2020
Honeywell’s project team has remotely and efficiently migrated Richter Gedeon’s process control system with limited onsite staffing and resources.
August 28, 2020
AbCellera’s recent acquisition of the OrthoMab bispecific platform is expected to accelerate antibody product development.